Bank of America Cuts Immunovant (NASDAQ:IMVT) Price Target to $45.00
Bank of America reduced their target price on Immunovant from $48.00 to $45.00 and set a “buy” rating on the stock in a research report on Wednesday.
Source link
Bank of America reduced their target price on Immunovant from $48.00 to $45.00 and set a “buy” rating on the stock in a research report on Wednesday.
Source link
August 2, 2024 by Leave a Comment Last Updated on August 2, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
There’s never been a better time to look at the Canadian mid-cap scene, especially if you believe that the Canadian stock market strength experienced last year will start really broadening out. Of course, there are plenty of major themes and tailwinds to play. While the rise of AI and agents might still be worth going…
What’s your coffee brand of choice? Me, as sophisticated as your favorite, stock-recommending gorilla is – a lot of the “fancy” stuff – just tastes burnt to me. When it comes to coffee… I’ll take the cheap stuff. Guess you can take the gorilla out of the lowlands – but you can’t take the lowlands…
AUD/USD – Starts the Reversal Source link
Domo, Inc. (NASDAQ:DOMO) Q1 2026 Earnings Conference Call May 21, 2025 5:00 PM ET Company Participants Peter Lowry – Vice President, Investor RelationsJosh James – Founder & Chief Executive OfficerTod Crane – Chief Financial OfficerRJ Tracy – Chief Revenue Officer Conference Call Participants Yi Fu Lee – Cantor FitzgeraldJared Jungjohann – TD CowenEric Martinuzzi –…
EAT Brinker International $63.00 -7.40 (-10.51%) (As of 08/14/2024 ET) 52-Week Range $28.23 ▼ $76.02 P/E Ratio 18.69 Price Target $57.34 Brinker International’s NYSE: EAT stock price fell 15% following its Q4 release, which presented an appetizing dip for investors to snack on. Weaker-than-expected earnings and softer-than-expected guidance caused the dip, but that is the worst…